ArticlePharmacoEconomics2019

Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.

Bunchai Chongmelaxme et al.PubMed ↗Publisher ↗

No numbers read from the abstract.